We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Automated Specialty Panels Test for Bacteria

By Labmedica staff writers
Posted on 02 Jan 2008
New instruments offer simultaneous automation of overnight, rapid, and specialty panels that test for both gram-negative and gram-positive bacteria. More...
The instruments are suitable for mid- and high-volume clinical diagnostic microbiology laboratories.

MicroScan technology was introduced as an advanced technology based on the microbiology principles of true minimum inhibitory concentration (MIC) testing. This principle is a very sensitive method to determine bacteria's susceptibility to antibiotics. The new WalkAway plus Systems combine MIC technology with new automated features, including automated maintenance and dial-up system diagnostics capability.

Launched by Siemens Medical Solutions (Deerfield, IL, USA) the new WalkAway plus systems also offer advanced automation features that improve laboratory productivity by decreasing system maintenance activity. The two new instrument models, a 40-panel capacity model for medium-volume laboratories and a 96-panel capacity model for high-volume laboratories, replace the current WalkAway SI 40 and 96 Systems.

Siemens Medical Solutions Diagnostics has nearly 60 MicroScan panels of tests, with up-to-date antibiotics including the overnight, rapid, and specialty panels. The company was the first to offer an automated identification and susceptibility testing system cleared for improved detection of the emerging resistant bacterium vancomycin-resistant Staphylococcus aureus (VRSA).

"We remain committed to addressing the challenges of today's clinical laboratory,” said Jim Reid-Anderson, president and CEO, Siemens Medical Solutions Diagnostics. "This new innovation for the microbiology laboratory allows customers to improve laboratory workflow and productivity while helping them to continue advancing the quality of patient care in their facilities.”

Siemens Medical Solutions provides medical solutions with core competence and innovative strength in diagnostic and therapeutic technologies. With its laboratory diagnostics acquisitions, Siemens Medical Solutions combines lab diagnostics, imaging, therapy, and healthcare information technology solutions, supplemented by consulting and support services.


Related Links:
Siemens Medical Solutions

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Immunofluorescence Analyzer
IFA System
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.